The role of interleukin-1β in pyoderma gangrenosum

Slides:

Advertisements

Similar presentations

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

Advertisements

Jeff Donovan, MD, PhD, FRCPC JAAD Case Reports

Volume 4, Issue 7, Pages (August 2018)

Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD JAAD Case Reports

Paula J. Beers, BS, Cheri N. Adgerson, MD, Susan B. Millan, MD

Flood syndrome JAAD Case Reports

Volume 1, Issue 5, Pages (September 2015)

Sara B. Ferguson, MD, Elisa S. Gallo, MD JAAD Case Reports

Volume 2, Issue 1, Pages 1-3 (January 2016)

Hemorrhagic lesion on the chest wall after trauma

Volume 1, Issue 5, Pages (September 2015)

A generalized fixed drug eruption associated with mycophenolate

Volume 1, Issue 5, Pages (September 2015)

Volume 3, Issue 3, Pages (May 2017)

An enlarging, ulcerated scalp nodule

Volume 4, Issue 5, Pages (June 2018)

Localized hypertrichosis after infectious rash in adults

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma

Flesh-colored papules and nodules on the face

Treatment of psoriasis vulgaris using low-dose naltrexone

Is the hip prosthesis responsible for this rash?

Lip edema Journal of the American Academy of Dermatology

Volume 4, Issue 10, Pages (November 2018)

Pierre-Olivier Grenier, MD, Hélène Veillette, MD, FRCPC

Mark D. Heibel, MD, Haley D. Heibel, MS JAAD Case Reports

Two cases of maggot debridement therapy in pyoderma gangrenosum

Successful treatment of livedoid vasculopathy with rivaroxaban

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC

Volume 1, Issue 1, Pages 7-8 (January 2015)

Allison Montgomery, BA, Jeffrey Kushner, DO, David Altman, MD

Neutrophilic dermatosis associated with mycosis fungoides

Recurrent breast cellulitis from a nipple fissure

Diffuse pruritic papules

Remission of psoriasis during treatment with sorafenib

Volume 4, Issue 6, Pages (July 2018)

Pediatric psoriasis treated with apremilast

Vulvovaginal pyoderma gangrenosum in association with rituximab

An atypical presentation of a rare disease

Rosai-Dorfman disease successfully treated with thalidomide

A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability Daniel J. Lewis, BA, Madeleine.

Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement Paul A. Leiphart, BA, Charlene C. Lam, MD,

Julia D. Stiegler, MD, Catherine T. Lucas, MD, Naveed Sami, MD

Jennifer E. Yeh, PhD, William G. Tsiaras, MD, PhD JAAD Case Reports

Volume 4, Issue 9, Pages (October 2018)

Slowly progressive chest rash in an elderly woman

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Circinate oral and genital mucositis

Volume 3, Issue 6, Pages (November 2017)

A case of rituximab-induced pyoderma gangrenosum

Divalproex sodium: A potential therapy for scleroderma digital ulcers

Papules developing in an old tattoo

Volume 4, Issue 7, Pages (August 2018)

Volume 1, Issue 6, Pages (November 2015)

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Heidrun Mitzel, MD, Stephan Grabbe, MD, Carmen Loquai, MD

Bilateral sole hyperkeratosis and nonhealing foot mass

Painful violaceus bullae of the hands

Widespread hyperpigmented rash present for 1 year

Treatment of monilethrix with oral minoxidil

Extensive skin necrosis

Multisystemic Langerhans cell histiocytosis in an adult

Lip ulceration in an immunocompromised patient

Well-circumscribed retiform ulcerations

Figurate erythema for 20 years

Bryan Baillis, MD, John C. Maize, MD JAAD Case Reports

Tattoo pigment removal by halo nevus phenomenon

Brian B. Johnson, MD, Lisa A. Beck, MD, S. Shahzad Mustafa, MD

Whitish elbow nodules in a healthy 11-year-old girl

Presentation transcript:

The role of interleukin-1β in pyoderma gangrenosum Ricardo Luis Galimberti, PhD, MD, Aldana Soledad Vacas, MD, María Luz Bollea Garlatti, MD, Ana Clara Torre, MD JAAD Case Reports Volume 2, Issue 5, Pages 366-368 (September 2016) DOI: 10.1016/j.jdcr.2016.07.007 Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Evolution of the ulcer in inner left lower leg. A, Before treatment. B, Two weeks after the last doses of canakinumab. C, 6 months after the beginning of treatment. JAAD Case Reports 2016 2, 366-368DOI: (10.1016/j.jdcr.2016.07.007) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Evolution of the ulcer in inner right lower leg. A, Before treatment. B, Two weeks after the last doses of canakinumab. C, None months after the beginning of treatment. JAAD Case Reports 2016 2, 366-368DOI: (10.1016/j.jdcr.2016.07.007) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions